(*) EU CE Mark Date: 2021. 09.06
(*) USA Approval Date: 2018. 09.24.
>2 Prior Therapies
Company
Company EU DIST:
Generic Name: duvelisib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 09.18.
PI3K: phosphoinositide 3-kinase
RTM
RTM Web-Site